Effects of atorvastatin on insulinemia and other atherosclerotic markers in patients with coronary artery disease

被引：0
|
作者：
Kuryat, O. V. [1 ]
Yegorova, Y. V. [1 ]
机构：
[1] Dnepropetrovsk State Med Acad, Dept Hosp Therapy 1, Dnepropetrovsk, Ukraine
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2007年 / 8卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(07)71789-0
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：207 / 207
页数：1
相关论文
共 50 条
  • [41] Prevalence and prediction of renal artery stenosis in patients with coronary and supraaortic artery atherosclerotic disease
    Przewlocki, Tadeusz
    Kablak-Ziembicka, Anna
    Tracz, Wieslawa
    Kopec, Grzegorz
    Rubis, Pawel
    Pasowicz, Mieczyslaw
    Musialek, Piotr
    Kostkiewicz, Magdalena
    Kozanecki, Artur
    Stompor, Tomasz
    Sulowicz, Wladyslaw
    Sokolowski, Andrzej
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (02) : 580 - 585
  • [42] Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease
    Ndrepepa, G.
    Tada, T.
    Fusaro, M.
    King, L.
    Hadamitzky, M.
    Haase, H. U.
    Schomig, A.
    Pache, J.
    Kastrati, A.
    EUROPEAN HEART JOURNAL, 2012, 33 : 783 - 783
  • [43] Eicosapentaenoic Acid Attenuates Coronary Atherosclerotic Plaque Volume in Patients with Coronary Artery Disease
    Katoh, Atsushi
    Tsuru, Tomoko
    Watanabe, Megumi
    Niiyama, Hiroshi
    Harada, Haruhito
    Nishiyama, Yasuhiro
    Yoshida, Noriko
    Yoh, Masayoshi
    Ikeda, Hisao
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (10) : S154 - S155
  • [44] Procalcitonin is an independent predictor for coronary atherosclerotic burden in patients with stable coronary artery disease
    Kurtul, Alparslan
    Elcik, Deniz
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 236 : 61 - 64
  • [45] Relationship between coronary atherosclerotic lesion and arterial stiffness in patients with coronary artery disease
    Yusupalieva, D.
    Shek, A.
    Nizamov, U.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [46] Effect of atorvastatin on serum omentin-1 in patients with coronary artery disease
    Chen, Qianqian
    Shang, Xingchen
    Yuan, Meng
    Liang, Lining
    Zhong, Xia
    CORONARY ARTERY DISEASE, 2017, 28 (01) : 44 - 51
  • [47] Procalcitonin is an independent predictor for coronary atherosclerotic burden in patients with stable coronary artery disease
    Kurtul, A.
    Elcik, D.
    EUROPEAN HEART JOURNAL, 2017, 38 : 187 - 187
  • [48] LIPID LOWERING EFFICACY OF ROSUVASTATIN VS ATORVASTATIN IN PATIENTS WITH CORONARY ARTERY DISEASE
    Ostergren, J.
    Malmstrom, R.
    Jorgensen, L.
    Walldius, G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 205 - 205
  • [49] Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease
    Alber, HF
    Dulak, J
    Frick, M
    Dichtl, W
    Schwarzacher, SP
    Pachinger, O
    Weidinger, F
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (12) : 1951 - 1955
  • [50] Effect of Atorvastatin on endothelium-dependent vasodilation in patients with coronary artery disease
    Vita, JA
    Gokce, N
    Duffy, SJ
    Kahn, D
    Tomasian, D
    Palmisano, J
    Thomas, S
    Holbrook, M
    Keaney, JF
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (07): : 857 - 860
12345